Zachmann M, Tassinari D, Sorgo W, Exner G U, Kempken B, Prader A
Acta Endocrinol (Copenh). 1982 Feb;99(2):166-73. doi: 10.1530/acta.0.0990166.
Twenty three boys with delayed adolescence (age 15.7 +/- 2.0, bone age 12.4 +/- 2.1 years) were studied. Their cortisol response to insulin was normal. After oral metyrapone (500 mg/m2 by mouth) one to three consecutive 12 h urine samples were collected for analysis of THS. Thirty seven tests with 37 first, 21 second, and 11 third samples were carried out. The results could be divided into two main groups: 25 tests (group A) were subnormal in the first sample, 12 of them with a very weak (40 +/- 8 micrograms/m2/12 h) and 13 with an insufficient (191 +/- 16 micrograms/m2/12 h) THS response. Values in the second and third sample were higher, indicating a delayed response. In 12 tests (group B), the results were normal (1016 +/- 143 micrograms/M2/12 h) in the first and lower in the second and third samples. In three patients with repeated tests, there was improvement with increasing bone age. The THS-responses to metyrapone did not correlate with those of growth hormone, gonadotrophins, and TSH to stimuli. It is concluded that the THS-response to a single dose of metyrapone may be temporarily insufficient or delayed in delayed adolescence. We interpret this finding as showing transiently reduced or slow hypothalamic responsiveness.
对23名青春期延迟的男孩(年龄15.7±2.0岁,骨龄12.4±2.1岁)进行了研究。他们对胰岛素的皮质醇反应正常。口服甲吡酮(500mg/m²)后,连续收集1至3次12小时的尿液样本用于促甲状腺激素(THS)分析。共进行了37次检测,其中37份为首次样本,21份为第二次样本,11份为第三次样本。结果可分为两个主要组:25次检测(A组)首次样本结果低于正常水平,其中12次促甲状腺激素反应非常弱(40±8微克/m²/12小时),13次反应不足(191±16微克/m²/12小时)。第二次和第三次样本的值较高,表明反应延迟。在12次检测(B组)中,首次样本结果正常(1016±143微克/M²/12小时),第二次和第三次样本结果较低。在3名进行重复检测的患者中,随着骨龄增加有改善。促甲状腺激素对甲吡酮的反应与生长激素、促性腺激素和促甲状腺激素对刺激的反应无关。结论是,在青春期延迟中,单次剂量甲吡酮的促甲状腺激素反应可能暂时不足或延迟。我们将这一发现解释为下丘脑反应性暂时降低或缓慢。